Researchers dig into why some neuroendocrine tumor treatments work better than others
NCT ID NCT06356467
Summary
This study aims to understand why some patients with neuroendocrine tumors respond better to treatments than others. Researchers will analyze medical records from 450 patients who received standard treatments to identify factors that influence how long treatments keep the cancer from progressing. The goal is to gather knowledge that could help doctors better predict treatment outcomes and personalize care in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS OSpedale San Raffaele
RECRUITINGMilan, 20132, Italy
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.